glp 1 agonist gastric emptying GLP-1 and Anesthesia: Considerations and Cautions for CRNAs Reflections on the discovery GLP-1
Description
Acta Neuropsychiatrica
Diabetes 64 , 715717 (2015)
2025;20:e70024
In the test of heterogeneity, I 2 = 0% and p = 0.62, indicating low heterogeneity
How tirzepatide addresses cardiovascular risk The Jorge 2026 study demonstrated that GLP-1 receptor agonists were associated with significantly lower risks of major adverse cardiovascular events in lupus patients compared to DPP-4 inhibitors
Black adults report the highest usage of GLP-1 medications among racial and ethnic groups, at 18%, followed by Hispanic adults at 13%
